Status:

COMPLETED

Understanding Sleep Problems in Children With Autism Spectrum Disorder

Lead Sponsor:

Baylor College of Medicine

Collaborating Sponsors:

Autism Speaks

Oregon Health and Science University

Conditions:

Sleep Problems

Eligibility:

All Genders

4-9 years

Brief Summary

The investigators will examine whether sleep problems in children with autism spectrum disorder (ASD) are related to alterations in the production of melatonin (MT), a hormone that plays an important ...

Detailed Description

This is a proposal to study the relationship between melatonin (MT) and sleep problems in children with autism spectrum disorder (ASD), as part of the collaborative research structure of the Autism Tr...

Eligibility Criteria

Inclusion

  • Diagnosis of Autism Spectrum Disorder; supported by ADOS and the ADI or SCQ (subjects).
  • Age greater than or equal to 4 or less than or equal to 9 years;
  • Parents have given informed consent.
  • Parent/Caregiver fluent in written and spoken English.
  • Controls only: A SCQ score of less than 10 without parental or physician concern for another neurodevelopmental disorder will be used to define normal children.

Exclusion

  • Current use of psychoactive medications (e.g. fluoxetine, methylphenidate, risperidone, lithium, etc.)\*;
  • Current or use within the last 1 month of beta-blockers or melatonin;
  • Current use of sleep aids;
  • Presence of untreated medical problems that could otherwise explain sleep problems (e.g. obstructive sleep apnea, gastroesophageal reflux disease - GERD);
  • Blindness.
  • Controls only: current or past diagnosis of ADHD, depression, anxiety or with any other psychiatric conditions. (7) Controls only: Sibling has a diagnosis of Autism Spectrum Disorder.
  • Psychoactive medications can be discontinued but the parents must discuss medication discontinuation with their prescribing physician prior to reducing or stopping the medications.

Key Trial Info

Start Date :

September 1 2007

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

November 1 2011

Estimated Enrollment :

58 Patients enrolled

Trial Details

Trial ID

NCT00691080

Start Date

September 1 2007

End Date

November 1 2011

Last Update

January 13 2016

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Columbia University

New York, New York, United States, 10032

2

Oregon Health & Sciences University

Portland, Oregon, United States, 97239

3

Baylor College of Medicine

Houston, Texas, United States, 77030